CEL-SCI Corporation (CVM) Pending Presentation
November 9, 2009 · Filed Under R&D
CEL-SCI Corporation (AMEX:CVM) will present at the 7th Annual Vaccines: All Things Considered Conference. The presenter is Dr.Daniel Zimmerman, Ph.D., Senior Vice President Research and Development
Novartis (NYSE:NVS), Sanofi Pasteur, and Merck (NYSE:MRK) are also expected to attend.
CEL-SCI is up 11% to $1.36 on heavy volume
Douglas A. McIntyre
